急性冠脉综合征 - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Abstract

BMI, Infarct Size, and Clinical Outcomes Following Primary PCI Patient-Level Analysis From 6 Randomized Trials
Evaluation and Management of Nonculprit Lesions in STEMI
Decreased inspired oxygen stimulates de novo formation of coronary collaterals in adult heart
Early versus delayed invasive intervention in acute coronary syndromes
Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI
New technologies for intensive prevention programs after myocardial infarction: rationale and design of the NET-IPP trial
Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCI
Heart Regeneration by Endogenous Stem Cells and Cardiomyocyte Proliferation: Controversy, Fallacy, and Progress
Imaging Coronary Anatomy and Reducing Myocardial Infarction
Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS-NSTEMI randomized trial

|<<... 10 11 12 13 14 15 16 ...>>|

Original Research

Volume 13, Issue 10, May 2020

JOURNAL：JACC: Cardiovascular Interventions

Article Link

Evaluation and Management of Nonculprit Lesions in STEMI

T Thim, NW van der Hoeven, C Musto et al.

5903

Keywords: CFR; FFR; iFR; nonculprit coronary lesions; STEMI

ABSTRACT

Nonculprit lesions are frequently observed in patients with ST-segment elevation myocardial infarction. Results from recent randomized clinical trials suggest that complete revascularization after ST-segment elevation myocardial infarction improves outcomes. In this state-of-the-art paper, the authors review these trials and consider how best to determine which nonculprit lesions require revascularization and when this should be performed.